Frontlight ResearchEarly access
Trial site
True North Clinical Research
- 2running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Phase
- Phase 33 trials
- Status
- Active, not recruiting2 trials
- Suspended1 trial
- Lead sponsor
- Eisai Inc.1 trial
- Eli Lilly and Company1 trial
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
Running trials
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Site data: ClinicalTrials.govUpdated 12 Nov 2026